Andrew Balicki

Papers

Total Citations

H-Index

About

Andrew Balicki is a head and neck surgeon and researcher whose work focuses on advancing transoral robotic surgery (TORS) for oropharyngeal cancers, particularly HPV-mediated squamous cell carcinoma. His major contribution lies in refining surgical margin assessment during TORS, where his landmark 2022 study investigated how specimen-based resection margins correlate with local control and survival outcomes. By analyzing whether positive margins revised to negative still impact recurrence and disease-free survival, Balicki has provided critical evidence that helps surgeons balance oncologic safety with functional preservation. His work directly informs intraoperative decision-making, reducing the need for adjuvant therapies while maintaining excellent local control rates. Though his most-cited paper currently holds 3 citations, its clinical significance is rapidly gaining recognition among surgical oncologists and head and neck specialists. Balicki’s research addresses a pressing clinical dilemma in the era of de-escalation protocols for HPV-positive disease, positioning him as an emerging authority in minimally invasive oncologic surgery. His findings are shaping how institutions standardize margin assessment protocols, ultimately improving outcomes for patients undergoing TORS.